Cargando…

Mass to voltage ratio index predicts mortality following TAVI

Transcatheter aortic valve implantation (TAVI) is commonly performed in elderly patients with aortic stenosis. Better methods of risk stratification are needed in this population with high morbidity. There is a relatively high incidence of cardiac amyloidosis in this population and high LV mass inde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porat, Alon, Gordon, Max, Perlman, Gidon, Planer, David, Danenberg, Haim, Alcalai, Ronny, Leibowitz, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544118/ https://www.ncbi.nlm.nih.gov/pubmed/35119184 http://dx.doi.org/10.1002/ccd.30117

Ejemplares similares

Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement
por: Berkovitch, Anat, et al.
Publicado: (2022)

Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI
por: Venturi, Gabriele, et al.
Publicado: (2022)

Time to TAVI: streamlining the pathway to treatment
por: Hewitson, Lynsey Jane, et al.
Publicado: (2023)

Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI‐NHR risk model
por: Al‐Farra, Hatem, et al.
Publicado: (2022)

Impact of social deprivation on outcome following transcatheter aortic valve implantation (TAVI)
por: Mohee, Kevin, et al.
Publicado: (2019)

Results and insights after 413 TAVI procedures performed by cardiac surgeons on their own
por: Malvindi, Pietro Giorgio, et al.
Publicado: (2023)

Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI
por: Ludwig, Sebastian, et al.
Publicado: (2022)

Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice
por: Lauten, Alexander, et al.
Publicado: (2021)

Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry
por: Saito, Tetsuya, et al.
Publicado: (2020)

Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis
por: Khawaja, M Z, et al.
Publicado: (2014)

Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
por: Lutz, Matthias, et al.
Publicado: (2017)

Utility of conventional aortic root shot angiography for SAPIEN 3 prosthesis sizing in TAVI: feasibility and inter-reader variability
por: Gansera, Laura, et al.
Publicado: (2019)

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry
por: Enta, Yusuke, et al.
Publicado: (2020)

Clinical value of the 20% logistic EuroSCORE cut-off for selecting TAVI candidates: a single-centre cohort study analysis
por: Imnadze, Guram, et al.
Publicado: (2020)

Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
por: Miyasaka, Masaki, et al.
Publicado: (2021)

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data
por: Freeman, Phillip M, et al.
Publicado: (2016)

Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry
por: Frank, Derk, et al.
Publicado: (2019)

Prognostic utility of N-terminal pro B-type natriuretic peptide ratio in mixed aortic valve disease
por: Bernard, Jérémy, et al.
Publicado: (2023)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation
por: von Stumm, Maria, et al.
Publicado: (2021)

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database
por: Ullah, Waqas, et al.
Publicado: (2022)

Dedicated plug based closure for large bore access –The MARVEL prospective registry
por: Kroon, Herbert G., et al.
Publicado: (2020)

Single center TAVR experience with a focus on the prevention and management of catastrophic complications
por: Kapadia, Samir R, et al.
Publicado: (2014)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study
por: Blackman, Daniel J., et al.
Publicado: (2019)

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
por: Kooistra, Nynke H., et al.
Publicado: (2020)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

TAVR and stroke: A common evolution
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Comparative differences of mitral valve‐in‐valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves
por: Wang, Dee Dee, et al.
Publicado: (2021)

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Doing procedures for patients rather than to patients
por: Malik, Shahbaz A., et al.
Publicado: (2022)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_puv8cd8jk7hb5s3k1klov1q0ep